{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:29:11Z","timestamp":1791311351875,"version":"4.3.1"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40266-024-01143-8","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:06:41Z","timestamp":1726510001000},"page":"795-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects"],"prefix":"10.1007","volume":"41","author":[{"given":"Kennedy","family":"Sparling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"5234","key":"1143_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270(5234):286\u201390. https:\/\/doi.org\/10.1126\/science.270.5234.286.","journal-title":"Science"},{"issue":"1","key":"1143_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. https:\/\/doi.org\/10.1186\/1710-1492-9-30.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"1143_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","volume":"178","author":"AM Drucker","year":"2018","unstructured":"Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018;178(3):768\u201375. https:\/\/doi.org\/10.1111\/bjd.15928.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1143_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.autrev.2019.02.005","volume":"18","author":"A Buonavoglia","year":"2019","unstructured":"Buonavoglia A, Leone P, Dammacco R, et al. Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy. Autoimmun Rev. 2019;18(4):349\u201358. https:\/\/doi.org\/10.1016\/j.autrev.2019.02.005.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/acr.21796","volume":"65","author":"RA Overman","year":"2013","unstructured":"Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2013;65(2):294\u20138. https:\/\/doi.org\/10.1002\/acr.21796.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"12","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40266-012-0029-9","volume":"29","author":"MW Marcus","year":"2012","unstructured":"Marcus MW, M\u00fcskens RP, Ramdas WD, et al. Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging. 2012;29(12):963\u201370. https:\/\/doi.org\/10.1007\/s40266-012-0029-9.","journal-title":"Drugs Aging"},{"issue":"3","key":"1143_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006;55(3):420\u20136. https:\/\/doi.org\/10.1002\/art.21984.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1143_CR8","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/jdv.18220","volume":"36","author":"L Borradori","year":"2022","unstructured":"Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022;36(10):1689\u2013704. https:\/\/doi.org\/10.1111\/jdv.18220.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1143_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","volume":"57","author":"C Chams-Davatchi","year":"2007","unstructured":"Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2007.05.024.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1143_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ddg.14097","volume":"18","author":"E Schmidt","year":"2020","unstructured":"Schmidt E, Sticherling M, S\u00e1rdy M, et al. S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid: 2019 update. J Dtsch Dermatol Ges. 2020;18(5):516\u201326. https:\/\/doi.org\/10.1111\/ddg.14097.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"1143_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaad.2017.09.074","volume":"78","author":"SH Yu","year":"2018","unstructured":"Yu SH, Drucker AM, Lebwohl M, Silverberg JI. A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol. 2018;78(4):733-740.e11. https:\/\/doi.org\/10.1016\/j.jaad.2017.09.074.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1143_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA. Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin North Am. 2016;42(1):15\u2013vii. https:\/\/doi.org\/10.1016\/j.rdc.2015.08.002.","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"1143_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398. https:\/\/doi.org\/10.2165\/00003088-200544010-00003.","journal-title":"Clin Pharmacokinet"},{"key":"1143_CR14","unstructured":"Kane SP. Corticosteroid Conversion Calculator. ClinCalc. Updated 24 October 2015. Available at: https:\/\/clincalc.com\/Corticosteroids. Accessed 23 Feb 2024."},{"issue":"1","key":"1143_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3177\/jnsv.53.37","volume":"53","author":"I Gom","year":"2007","unstructured":"Gom I, Fukushima H, Shiraki M, et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol (Tokyo). 2007;53(1):37\u201342. https:\/\/doi.org\/10.3177\/jnsv.53.37.","journal-title":"J Nutr Sci Vitaminol (Tokyo)."},{"issue":"9","key":"1143_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","volume":"114","author":"JM Piper","year":"1991","unstructured":"Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114(9):735\u201340. https:\/\/doi.org\/10.7326\/0003-4819-114-9-735.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1143_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/apt.13298","volume":"42","author":"CL Tseng","year":"2015","unstructured":"Tseng CL, Chen YT, Huang CJ, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study. Aliment Pharmacol Ther. 2015;42(5):599\u2013606. https:\/\/doi.org\/10.1111\/apt.13298.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"1143_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1532-5415.1994.tb06219.x","volume":"42","author":"KM Tornatore","year":"1994","unstructured":"Tornatore KM, Logue G, Venuto RC, Davis PJ. Pharmacokinetics of methylprednisolone in elderly and young healthy males. J Am Geriatr Soc. 1994;42(10):1118\u201322. https:\/\/doi.org\/10.1111\/j.1532-5415.1994.tb06219.x.","journal-title":"J Am Geriatr Soc"},{"key":"1143_CR19","unstructured":"Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2023. Available at: https:\/\/ginasthma.org\/2023-gina-main-report\/. Accessed 23 Aug 2023."},{"issue":"6","key":"1143_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.14309\/ajg.0000000000001748","volume":"117","author":"JS Bajaj","year":"2022","unstructured":"Bajaj JS, Wong F, Kamath PS, Lai JC, O\u2019Leary JG. Acute-on-chronic liver failure. Am J Gastroenterol. 2022;117(6):831\u20134. https:\/\/doi.org\/10.14309\/ajg.0000000000001748.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1143_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, et al. Bullous Diseases French Study Group. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321\u20137. https:\/\/doi.org\/10.1056\/NEJMoa011592.","journal-title":"N Engl J Med"},{"issue":"3","key":"1143_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/ard.2005.038638","volume":"65","author":"JA Da Silva","year":"2006","unstructured":"Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65(3):285\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1143_CR23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119\u201324. https:\/\/doi.org\/10.1136\/ard.2008.092163.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1143_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","volume":"96","author":"KG Saag","year":"1994","unstructured":"Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96(2):115\u201323. https:\/\/doi.org\/10.1016\/0002-9343(94)90131-7.","journal-title":"Am J Med"},{"issue":"2","key":"1143_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1253\/circj.CJ-18-0807","volume":"83","author":"SM Ito","year":"2019","unstructured":"Ito SM, Yamanashi Y, Takada T, Suzuki H. Clinical importance of drug\u2013drug interaction between warfarin and prednisolone and its potential mechanism in relation to the Niemann-Pick C1-like 1-mediated pathway. Circ J. 2019;83(2):471\u201380. https:\/\/doi.org\/10.1253\/circj.CJ-18-0807.","journal-title":"Circ J"},{"issue":"10","key":"1143_CR26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/thx.51.10.1057","volume":"51","author":"SF Smith","year":"1996","unstructured":"Smith SF. Lipocortin 1. glucocorticoids caught in the act? Thorax. 1996;51(10):1057\u20139. https:\/\/doi.org\/10.1136\/thx.51.10.1057.","journal-title":"Thorax"},{"issue":"1","key":"1143_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.04.005.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"1143_CR28","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","volume":"39","author":"JB Rice","year":"2017","unstructured":"Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216\u201329. https:\/\/doi.org\/10.1016\/j.clinthera.2017.09.011.","journal-title":"Clin Ther"},{"issue":"Suppl 5","key":"1143_CR29","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1513\/AnnalsATS.201602-095AW","volume":"13","author":"CM Weyand","year":"2016","unstructured":"Weyand CM, Goronzy JJ. Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc. 2016;13(Suppl 5):S422\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.201602-095AW.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"1143_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002024","volume":"13","author":"L Fardet","year":"2016","unstructured":"Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med. 2016;13(5): e1002024. https:\/\/doi.org\/10.1371\/journal.pmed.1002024.","journal-title":"PLoS Med"},{"issue":"7","key":"1143_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/jhm.13095","volume":"18","author":"SS Kumar","year":"2023","unstructured":"Kumar SS, Arvind S, Umpierrez AP. Things We Do for No Reason\u2122: Routine use of proton pump inhibitors for peptic ulcer prophylaxis in adults on high-dose corticosteroids. J Hosp Med. 2023;18(7):630\u20132. https:\/\/doi.org\/10.1002\/jhm.13095.","journal-title":"J Hosp Med"},{"issue":"25","key":"1143_CR32","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.2174\/1381612826666200521142746","volume":"26","author":"L Filaretova","year":"2020","unstructured":"Filaretova L, Podvigina T, Yarushkina N. Physiological and pharmacological effects of glucocorticoids on the gastrointestinal tract. Curr Pharm Des. 2020;26(25):2962\u201370. https:\/\/doi.org\/10.2174\/1381612826666200521142746.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1143_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0749-0690(18)30042-9","volume":"15","author":"ML Borum","year":"1999","unstructured":"Borum ML. Peptic-ulcer disease in the elderly. Clin Geriatr Med. 1999;15(3):457\u201371.","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"1143_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamainternmed.2013.2737","volume":"173","author":"O Sadr-Azodi","year":"2013","unstructured":"Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013;173(6):444\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2013.2737.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1143_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10067-003-0793-3","volume":"23","author":"CT Derk","year":"2004","unstructured":"Derk CT, DeHoratius RJ. Systemic lupus erythematosus and acute pancreatitis: a case series. Clin Rheumatol. 2004;23(2):147\u201351. https:\/\/doi.org\/10.1007\/s10067-003-0793-3.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"1143_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","volume":"6","author":"HE Tamez-P\u00e9rez","year":"2015","unstructured":"Tamez-P\u00e9rez HE, Quintanilla-Flores DL, Rodr\u00edguez-Guti\u00e9rrez R, Gonz\u00e1lez-Gonz\u00e1lez JG, Tamez-Pe\u00f1a AL. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6(8):1073\u201381. https:\/\/doi.org\/10.4239\/wjd.v6.i8.1073.","journal-title":"World J Diabetes"},{"issue":"2","key":"1143_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/jpm12020280","volume":"12","author":"R Markovi\u010d","year":"2022","unstructured":"Markovi\u010d R, Grubelnik V, Vo\u0161ner HB, et al. Age-related changes in lipid and glucose levels associated with drug use and mortality: an observational study. J Pers Med. 2022;12(2):280. https:\/\/doi.org\/10.3390\/jpm12020280.","journal-title":"J Pers Med."},{"key":"1143_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fgene.2017.00216","volume":"8","author":"T Head","year":"2017","unstructured":"Head T, Daunert S, Goldschmidt-Clermont PJ. The aging risk and atherosclerosis: a fresh look at arterial homeostasis. Front Genet. 2017;8:216. https:\/\/doi.org\/10.3389\/fgene.2017.00216.","journal-title":"Front Genet"},{"issue":"4","key":"1143_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/art.21329","volume":"53","author":"HK Choi","year":"2005","unstructured":"Choi HK, Seeger JD. Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005;53(4):528\u201335. https:\/\/doi.org\/10.1002\/art.21329.","journal-title":"Arthritis Rheum"},{"key":"1143_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/OARRR.S245662","volume":"12","author":"N Atik","year":"2020","unstructured":"Atik N, Hayati RU, Hamijoyo L. Correlation between steroid therapy and lipid profile in systemic lupus erythematosus patients. Open Access Rheumatol. 2020;12:41\u20136. https:\/\/doi.org\/10.2147\/OARRR.S245662.","journal-title":"Open Access Rheumatol"},{"issue":"11","key":"1143_CR41","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1001\/archinte.1987.00370110045006","volume":"147","author":"KL Svenson","year":"1987","unstructured":"Svenson KL, Lithell H, H\u00e4llgren R, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med. 1987;147(11):1917\u201320.","journal-title":"Arch Intern Med"},{"key":"1143_CR42","unstructured":"National Heart Lung and Blood Institute. Diagnosis. Available at: https:\/\/www.nhlbi.nih.gov\/health\/blood-cholesterol\/diagnosis#:~:text=Screening%20may%20be%20performed%20as,every%201%20to%202%20years. Accessed 15 Apr 2024."},{"issue":"10","key":"1143_CR43","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012. JAMA. 2015;314(10):1021\u20139. https:\/\/doi.org\/10.1001\/jama.2015.10029.","journal-title":"JAMA"},{"issue":"1","key":"1143_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","volume":"154","author":"JH Gurwitz","year":"1994","unstructured":"Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994;154(1):97\u2013101.","journal-title":"Arch Intern Med"},{"issue":"2","key":"1143_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/dmrr.2486","volume":"30","author":"JL Hwang","year":"2014","unstructured":"Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014;30(2):96\u2013102. https:\/\/doi.org\/10.1002\/dmrr.2486.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"1143_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/00007890-199102000-00020","volume":"51","author":"DE Hricik","year":"1991","unstructured":"Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation. 1991;51(2):374\u20137. https:\/\/doi.org\/10.1097\/00007890-199102000-00020.","journal-title":"Transplantation"},{"issue":"3","key":"1143_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2337\/ds18-0033","volume":"31","author":"E Leung","year":"2018","unstructured":"Leung E, Wongrakpanich S, Munshi MN. Diabetes management in the elderly. Diabetes Spectr. 2018;31(3):245\u201353. https:\/\/doi.org\/10.2337\/ds18-0033.","journal-title":"Diabetes Spectr"},{"key":"1143_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103202","volume":"36","author":"J Bini","year":"2022","unstructured":"Bini J, Parikh L, Lacadie C, et al. Stress-level glucocorticoids increase fasting hunger and decrease cerebral blood flow in regions regulating eating. Neuroimage Clin. 2022;36: 103202. https:\/\/doi.org\/10.1016\/j.nicl.2022.103202.","journal-title":"Neuroimage Clin."},{"key":"1143_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2007.04.018","volume":"57","author":"L Fardet","year":"2007","unstructured":"Fardet L, Cabane J, Lebb\u00e9 C, Morel P, Flahault A. Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. J Am Acad Dermatol. 2007;57:604\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2007.04.018.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1143_CR50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","volume":"157","author":"L Fardet","year":"2007","unstructured":"Fardet L, Flahault A, Kettaneh A, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol. 2007;157(1):142\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07950.x.","journal-title":"Br J Dermatol"},{"issue":"8","key":"1143_CR51","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A. Endocrine society. Treatment of cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1143_CR52","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/ard-2023-224185","volume":"82","author":"H So","year":"2023","unstructured":"So H, Lam TO, Meng H, Lam SHM, Tam LS. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2023;82(11):1387\u201393. https:\/\/doi.org\/10.1136\/ard-2023-224185.","journal-title":"Ann Rheum Dis"},{"key":"1143_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357: j2099. https:\/\/doi.org\/10.1136\/bmj.j2099.","journal-title":"BMJ"},{"key":"1143_CR54","doi-asserted-by":"publisher","first-page":"1077632","DOI":"10.3389\/fendo.2022.1077632","volume":"13","author":"X Mu","year":"2022","unstructured":"Mu X, Wu A, Hu H, Zhou H, Yang M. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022;13:1077632.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"1143_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1559827618812395","volume":"13","author":"JM Rippe","year":"2018","unstructured":"Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am J Lifestyle Med. 2018;13(2):204\u201312. https:\/\/doi.org\/10.1177\/1559827618812395.","journal-title":"Am J Lifestyle Med"},{"issue":"10338","key":"1143_CR56","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","volume":"399","author":"J Delgado-Lista","year":"2022","unstructured":"Delgado-Lista J, Alcala-Diaz JF, Torres-Pe\u00f1a JD, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet. 2022;399(10338):1876\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(22)00122-2.","journal-title":"Lancet"},{"issue":"5","key":"1143_CR57","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ki.1987.131","volume":"31","author":"JA Whitworth","year":"1987","unstructured":"Whitworth JA. Mechanisms of glucocorticoid-induced hypertension. Kidney Int. 1987;31(5):1213\u201324. https:\/\/doi.org\/10.1038\/ki.1987.131.","journal-title":"Kidney Int"},{"issue":"Suppl 7","key":"1143_CR58","doi-asserted-by":"publisher","first-page":"381s","DOI":"10.1042\/cs061381s","volume":"61","author":"SH Jackson","year":"1981","unstructured":"Jackson SH, Beevers DG, Myers K. Does long-term low-dose corticosteroid therapy cause hypertension? Clin Sci (Lond). 1981;61(Suppl 7):381s\u20133s. https:\/\/doi.org\/10.1042\/cs061381s.","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"1143_CR59","doi-asserted-by":"publisher","first-page":"E295","DOI":"10.1503\/cmaj.191012","volume":"192","author":"TF Mebrahtu","year":"2020","unstructured":"Mebrahtu TF, Morgan AW, West RM, Stewart PM, Pujades-Rodriguez M. Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study. CMAJ. 2020;192(12):E295\u2013301. https:\/\/doi.org\/10.1503\/cmaj.191012.","journal-title":"CMAJ"},{"issue":"2","key":"1143_CR60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/01.hyp.7.2.292","volume":"7","author":"JP Gr\u00fcnfeld","year":"1985","unstructured":"Gr\u00fcnfeld JP, Eloy L, Moura AM, Ganeval D, Ramos-Frendo B, Worcel M. Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. Hypertension. 1985;7(2):292\u20139. https:\/\/doi.org\/10.1161\/01.hyp.7.2.292.","journal-title":"Hypertension"},{"issue":"9623","key":"1143_CR61","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes CM, Vander Hoorn S, Rodgers A. International Society of H. global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513\u20138.","journal-title":"Lancet"},{"issue":"9","key":"1143_CR62","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","volume":"166","author":"CS van der Hooft","year":"2006","unstructured":"van der Hooft CS, Heeringa J, Brusselle GG, et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med. 2006;166(9):1016\u201320. https:\/\/doi.org\/10.1001\/archinte.166.9.1016.","journal-title":"Arch Intern Med"},{"issue":"18","key":"1143_CR63","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","volume":"169","author":"CF Christiansen","year":"2009","unstructured":"Christiansen CF, Christensen S, Mehnert F, Cummings SR, Chapurlat RD, S\u00f8rensen HT. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study. Arch Intern Med. 2009;169(18):1677\u201383. https:\/\/doi.org\/10.1001\/archinternmed.2009.297.","journal-title":"Arch Intern Med"},{"issue":"12","key":"1143_CR64","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00296-018-4167-1","volume":"38","author":"D \u00dcsk\u00fcdar Cansu","year":"2018","unstructured":"\u00dcsk\u00fcdar Cansu D, Bodak\u00e7i E, Korkmaz C. Dose-dependent bradycardia as a rare side effect of corticosteroids: a case report and review of the literature. Rheumatol Int. 2018;38(12):2337\u201343. https:\/\/doi.org\/10.1007\/s00296-018-4167-1.","journal-title":"Rheumatol Int"},{"key":"1143_CR65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.wneu.2016.01.033","volume":"89","author":"BA Lieber","year":"2016","unstructured":"Lieber BA, Han J, Appelboom G, et al. Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis. World Neurosurg. 2016;89:126\u201332. https:\/\/doi.org\/10.1016\/j.wneu.2016.01.033.","journal-title":"World Neurosurg."},{"key":"1143_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11239-009-0378-3","volume":"28","author":"FA Spencer","year":"2009","unstructured":"Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009;28:401\u20139. https:\/\/doi.org\/10.1007\/s11239-009-0378-3.","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"1143_CR67","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","volume":"2","author":"HJ Sch\u00fcnemann","year":"2018","unstructured":"Sch\u00fcnemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients [published correction appears in Blood Adv. 2023 May;7(9):1671]. Blood Adv. 2018;2(22):3198\u2013225. https:\/\/doi.org\/10.1182\/bloodadvances.2018022954.","journal-title":"Blood Adv"},{"issue":"4","key":"1143_CR68","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00006324-197704000-00010","volume":"54","author":"WF Long","year":"1977","unstructured":"Long WF. A case of elevated intraocular pressure associated with systemic steroid therapy. Am J Optom Physiol Opt. 1977;54(4):248\u201352. https:\/\/doi.org\/10.1097\/00006324-197704000-00010.","journal-title":"Am J Optom Physiol Opt"},{"issue":"1","key":"1143_CR69","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.1038\/s41598-021-92971-w","volume":"11","author":"N Zhang","year":"2021","unstructured":"Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11(1):13762. https:\/\/doi.org\/10.1038\/s41598-021-92971-w.","journal-title":"Sci Rep"},{"issue":"1","key":"1143_CR70","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12886-021-02168-y","volume":"21","author":"GM Wubet","year":"2021","unstructured":"Wubet GM, Assefa AA. Glaucoma and its predictors among adult patients attending ophthalmic outpatient department: a hospital-based study, North West Ethiopia. BMC Ophthalmol. 2021;21(1):400. https:\/\/doi.org\/10.1186\/s12886-021-02168-y.","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"1143_CR71","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11686","volume":"12","author":"K Allison","year":"2020","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12(11): e11686. https:\/\/doi.org\/10.7759\/cureus.11686.","journal-title":"Cureus."},{"issue":"2","key":"1143_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","volume":"11","author":"S Phulke","year":"2017","unstructured":"Phulke S, Kaushik S, Kaur S, Pandav SS. Steroid-induced Glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract. 2017;11(2):67\u201372.","journal-title":"J Curr Glaucoma Pract."},{"issue":"2","key":"1143_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2229-5178.85993","volume":"2","author":"JS Mandapati","year":"2011","unstructured":"Mandapati JS, Metta AK. Intraocular pressure variation in patients on long-term corticosteroids. Indian Dermatol Online J. 2011;2(2):67\u20139. https:\/\/doi.org\/10.4103\/2229-5178.85993.","journal-title":"Indian Dermatol Online J"},{"issue":"13","key":"1143_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3238\/arztebl.2020.0225","volume":"117","author":"AK Schuster","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, et al. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020;117(13):225\u201334. https:\/\/doi.org\/10.3238\/arztebl.2020.0225.","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"1143_CR75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","volume":"111","author":"R Haimovici","year":"2004","unstructured":"Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111(2):244\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2003.09.024.","journal-title":"Ophthalmology"},{"key":"1143_CR76","first-page":"35","volume":"289","author":"E De Nijs","year":"2003","unstructured":"De Nijs E, Brabant P, De Laey JJ. The adverse effects of corticosteroids in central serous chorioretinopathy. Bull Soc Belge Ophtalmol. 2003;289:35\u201341.","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"6","key":"1143_CR77","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","volume":"30","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019;30(6):1145\u201356. https:\/\/doi.org\/10.1007\/s00198-019-04906-x.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1143_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.afos.2020.02.002","volume":"6","author":"SPY Wong","year":"2020","unstructured":"Wong SPY, Mok CC. Management of glucocorticoid-related osteoporotic vertebral fracture. Osteoporos Sarcopenia. 2020;6(1):1\u20137. https:\/\/doi.org\/10.1016\/j.afos.2020.02.002.","journal-title":"Osteoporos Sarcopenia."},{"issue":"10","key":"1143_CR79","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP van Staa","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13(10):777\u201387. https:\/\/doi.org\/10.1007\/s001980200108.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1143_CR80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jocd.2018.03.004","volume":"22","author":"RA Adler","year":"2019","unstructured":"Adler RA. Glucocorticoid-induced osteoporosis: management challenges in older patients. J Clin Densitom. 2019;22(1):20\u20134. https:\/\/doi.org\/10.1016\/j.jocd.2018.03.004.","journal-title":"J Clin Densitom"},{"issue":"12","key":"1143_CR81","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/acr.25240","volume":"75","author":"MB Humphrey","year":"2023","unstructured":"Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2023;75(12):2405\u201319. https:\/\/doi.org\/10.1002\/acr.25240.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"12","key":"1143_CR82","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1210\/jc.2011-1600","volume":"96","author":"AL Skversky","year":"2011","unstructured":"Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006. J Clin Endocrinol Metab. 2011;96(12):3838\u201345. https:\/\/doi.org\/10.1210\/jc.2011-1600.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1143_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkad019","volume":"7","author":"S Kast","year":"2023","unstructured":"Kast S, Jakob F, Kohl M, et al. Exercise effects on glucocorticoid-induced bone loss in adults: a systematic review and meta-analysis. Rheumatol Adv Pract. 2023;7(1): rkad019. https:\/\/doi.org\/10.1093\/rap\/rkad019.","journal-title":"Rheumatol Adv Pract"},{"issue":"10","key":"1143_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001347.pub2","volume":"10","author":"CS Allen","year":"2016","unstructured":"Allen CS, Yeung JH, Vandermeer B, Homik J. Bisphosphonates for steroid-induced osteoporosis. Cochrane Database Syst Rev. 2016;10(10): CD001347. https:\/\/doi.org\/10.1002\/14651858.CD001347.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7 Suppl","key":"1143_CR85","first-page":"16","volume":"33","author":"R Carpinteri","year":"2010","unstructured":"Carpinteri R, Porcelli T, Mejia C, et al. Glucocorticoid-induced osteoporosis and parathyroid hormone. J Endocrinol Invest. 2010;33(7 Suppl):16\u201321.","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"1143_CR86","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/rheumatology\/ker277","volume":"50","author":"T Shigemura","year":"2011","unstructured":"Shigemura T, Nakamura J, Kishida S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/ker277.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1143_CR87","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jot.2014.12.002","volume":"3","author":"XH Xie","year":"2015","unstructured":"Xie XH, Wang XL, Yang HL, Zhao DW, Qin L. Steroid-associated osteonecrosis: epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview). J Orthop Translat. 2015;3(2):58\u201370. https:\/\/doi.org\/10.1016\/j.jot.2014.12.002.","journal-title":"J Orthop Translat."},{"issue":"5","key":"1143_CR88","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00198-018-04826-2","volume":"30","author":"J Bergman","year":"2019","unstructured":"Bergman J, Nordstr\u00f6m A, Nordstr\u00f6m P. Epidemiology of osteonecrosis among older adults in Sweden. Osteoporos Int. 2019;30(5):965\u201373. https:\/\/doi.org\/10.1007\/s00198-018-04826-2.","journal-title":"Osteoporos Int"},{"issue":"9","key":"1143_CR89","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.arth.2015.03.036","volume":"30","author":"MA Mont","year":"2015","unstructured":"Mont MA, Pivec R, Banerjee S, Issa K, Elmallah RK, Jones LC. High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review. J Arthroplasty. 2015;30(9):1506-1512.e5. https:\/\/doi.org\/10.1016\/j.arth.2015.03.036.","journal-title":"J Arthroplasty"},{"issue":"2","key":"1143_CR90","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41(2):183\u201390. https:\/\/doi.org\/10.1007\/s12020-011-9580-0.","journal-title":"Endocrine"},{"issue":"12","key":"1143_CR91","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.crad.2004.04.014","volume":"59","author":"A Saini","year":"2004","unstructured":"Saini A, Saifuddin A. MRI of osteonecrosis. Clin Radiol. 2004;59(12):1079\u201393. https:\/\/doi.org\/10.1016\/j.crad.2004.04.014.","journal-title":"Clin Radiol"},{"issue":"1","key":"1143_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008;197(1):1\u201310. https:\/\/doi.org\/10.1677\/JOE-07-0606.","journal-title":"J Endocrinol"},{"issue":"8","key":"1143_CR93","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1212\/wnl.41.8.1235","volume":"41","author":"EJ Dropcho","year":"1991","unstructured":"Dropcho EJ, Soong SJ. Steroid-induced weakness in patients with primary brain tumors. Neurology. 1991;41(8):1235\u20139. https:\/\/doi.org\/10.1212\/wnl.41.8.1235.","journal-title":"Neurology"},{"issue":"5","key":"1143_CR94","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4103\/2230-8210.117215","volume":"17","author":"A Gupta","year":"2013","unstructured":"Gupta A, Gupta Y. Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab. 2013;17(5):913\u20136. https:\/\/doi.org\/10.4103\/2230-8210.117215.","journal-title":"Indian J Endocrinol Metab."},{"key":"1143_CR95","unstructured":"Surmachevska N, Tiwari V. Corticosteroid Induced Myopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"issue":"2","key":"1143_CR96","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3945\/ajcn.110.005611","volume":"93","author":"GI Smith","year":"2011","unstructured":"Smith GI, Atherton P, Reeds DN, et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr. 2011;93(2):402\u201312. https:\/\/doi.org\/10.3945\/ajcn.110.005611.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1143_CR97","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/foods11050687","volume":"11","author":"MK Lee","year":"2022","unstructured":"Lee MK, Jeong HH, Kim MJ, Ryu H, Baek J, Lee B. Nutrients against glucocorticoid-induced muscle atrophy. Foods. 2022;11(5):687. https:\/\/doi.org\/10.3390\/foods11050687.","journal-title":"Foods"},{"issue":"1","key":"1143_CR98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/gerona\/glab232","volume":"77","author":"RR Deer","year":"2022","unstructured":"Deer RR, Hosein E, Mera A, et al. Dietary intake patterns of community-dwelling older adults after acute hospitalization. J Gerontol A Biol Sci Med Sci. 2022;77(1):140\u20137. https:\/\/doi.org\/10.1093\/gerona\/glab232.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1143_CR99","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1183\/09031936.98.11010139","volume":"11","author":"K Haapasaari","year":"1998","unstructured":"Haapasaari K, Rossi O, Risteli J, Oikarinen A. Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients. Eur Respir J. 1998;11(1):139\u201343. https:\/\/doi.org\/10.1183\/09031936.98.11010139.","journal-title":"Eur Respir J"},{"issue":"1","key":"1143_CR100","first-page":"15","volume":"82","author":"IK Cohen","year":"1977","unstructured":"Cohen IK, Diegelmann RF, Johnson ML. Effect of corticosteroids on collagen synthesis. Surgery. 1977;82(1):15\u201320.","journal-title":"Surgery"},{"issue":"1","key":"1143_CR101","first-page":"13","volume":"11","author":"JM Dyer","year":"2018","unstructured":"Dyer JM, Miller RA. Chronic skin fragility of aging: current concepts in the pathogenesis, recognition, and management of dermatoporosis. J Clin Aesthet Dermatol. 2018;11(1):13\u20138.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"5","key":"1143_CR102","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jop.2006.0067","volume":"23","author":"ER James","year":"2007","unstructured":"James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23(5):403\u201320. https:\/\/doi.org\/10.1089\/jop.2006.0067.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1143_CR103","doi-asserted-by":"publisher","first-page":"1110383","DOI":"10.3389\/fmed.2023.1110383","volume":"10","author":"R Mencucci","year":"2023","unstructured":"Mencucci R, Stefanini S, Favuzza E, Cennamo M, De Vitto C, Mossello E. Beyond vision: cataract and health status in old age, a narrative review. Front Med (Lausanne). 2023;10:1110383. https:\/\/doi.org\/10.3389\/fmed.2023.1110383.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"1143_CR104","first-page":"378","volume":"127","author":"AA Halpern","year":"1977","unstructured":"Halpern AA, Horowitz BG, Nagel DA. Tendon ruptures associated with corticosteroid therapy. West J Med. 1977;127(5):378\u201382.","journal-title":"West J Med"},{"issue":"20","key":"1143_CR105","doi-asserted-by":"publisher","first-page":"15183","DOI":"10.3390\/ijms242015183","volume":"24","author":"KYC Kwan","year":"2023","unstructured":"Kwan KYC, Ng KWK, Rao Y, et al. Effect of aging on tendon biology, biomechanics and implications for treatment approaches. Int J Mol Sci. 2023;24(20):15183. https:\/\/doi.org\/10.3390\/ijms242015183.","journal-title":"Int J Mol Sci"},{"key":"1143_CR106","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fncel.2012.00015","volume":"6","author":"HJ Krugers","year":"2012","unstructured":"Krugers HJ, Karst H, Joels M. Interactions between noradrenaline and corticosteroids in the brain: from electrical activity to cognitive performance. Front Cell Neurosci. 2012;6:15. https:\/\/doi.org\/10.3389\/fncel.2012.00015.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"1143_CR107","first-page":"667","volume":"55","author":"A Czyrak","year":"2003","unstructured":"Czyrak A, Ma\u0107kowiak M, Chocyk A, Fija\u0142 K, Wedzony K. Role of glucocorticoids in the regulation of dopaminergic neurotransmission. Pol J Pharmacol. 2003;55(5):667\u201374.","journal-title":"Pol J Pharmacol"},{"issue":"1","key":"1143_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0006-8993(80)91160-9","volume":"190","author":"D Schubert","year":"1980","unstructured":"Schubert D, LaCorbiere M, Klier FG, Steinbach JH. The modulation of neurotransmitter synthesis by steroid hormones and insulin. Brain Res. 1980;190(1):67\u201379. https:\/\/doi.org\/10.1016\/0006-8993(80)91160-9.","journal-title":"Brain Res"},{"issue":"1","key":"1143_CR109","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.NME.0000723400.84384.2b","volume":"19","author":"R Pullen","year":"2021","unstructured":"Pullen R. Mental status changes with corticosteroid therapy. Nursing Made Incredibly Easy. 2021;19(1):55\u20136. https:\/\/doi.org\/10.1097\/01.NME.0000723400.84384.2b.","journal-title":"Nursing Made Incredibly Easy."},{"issue":"5","key":"1143_CR110","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/10253890.2018.1470238","volume":"21","author":"JK Gjerstad","year":"2018","unstructured":"Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403\u201316. https:\/\/doi.org\/10.1080\/10253890.2018.1470238.","journal-title":"Stress"},{"issue":"1","key":"1143_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4088\/pcc.v03n0104","volume":"3","author":"ES Brown","year":"2001","unstructured":"Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3(1):17\u201321. https:\/\/doi.org\/10.4088\/pcc.v03n0104.","journal-title":"Prim Care Companion J Clin Psychiatry."},{"issue":"5","key":"1143_CR112","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1081-1206(10)61756-5","volume":"92","author":"SH Bolanos","year":"2004","unstructured":"Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92(5):500\u20135. https:\/\/doi.org\/10.1016\/S1081-1206(10)61756-5.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1143_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00004714-200202000-00009","volume":"22","author":"ES Brown","year":"2002","unstructured":"Brown ES, Suppes T, Khan DA, Carmody TJ 3rd. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol. 2002;22(1):55\u201361. https:\/\/doi.org\/10.1097\/00004714-200202000-00009.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"1143_CR114","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","volume":"169","author":"L Fardet","year":"2012","unstructured":"Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169(5):491\u20137. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11071009.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1143_CR115","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1212\/wnl.47.6.1396","volume":"47","author":"PA Keenan","year":"1996","unstructured":"Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology. 1996;47(6):1396\u2013402. https:\/\/doi.org\/10.1212\/wnl.47.6.1396.","journal-title":"Neurology"},{"issue":"10","key":"1143_CR116","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1212\/wnl.38.10.1631","volume":"38","author":"SL Minden","year":"1988","unstructured":"Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology. 1988;38(10):1631\u20134. https:\/\/doi.org\/10.1212\/wnl.38.10.1631.","journal-title":"Neurology"},{"issue":"2","key":"1143_CR117","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","volume":"53","author":"AN Dubovsky","year":"2012","unstructured":"Dubovsky AN, Arvikar S, Stern TA, Axelrod L. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics. 2012;53(2):103\u201315. https:\/\/doi.org\/10.1016\/j.psym.2011.12.007.","journal-title":"Psychosomatics"},{"key":"1143_CR118","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","volume":"1179","author":"OM Wolkowitz","year":"2009","unstructured":"Wolkowitz OM, Burke H, Epel ES, Reus VI. Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci. 2009;1179:19\u201340. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04980.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1143_CR119","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1440-1819.2011.02260.x","volume":"65","author":"HA Kenna","year":"2011","unstructured":"Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65(6):549\u201360. https:\/\/doi.org\/10.1111\/j.1440-1819.2011.02260.x.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"1143_CR120","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/medicines5030082","volume":"5","author":"C Manzo","year":"2018","unstructured":"Manzo C, Serra-Mestres J, Castagna A, Isetta M. Behavioral, psychiatric, and cognitive adverse events in older persons treated with glucocorticoids. Medicines (Basel). 2018;5(3):82. https:\/\/doi.org\/10.3390\/medicines5030082.","journal-title":"Medicines (Basel)."},{"issue":"2","key":"1143_CR121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/medsci9020031","volume":"9","author":"CE McCarthy","year":"2021","unstructured":"McCarthy CE. Sleep disturbance, sleep disorders and co-morbidities in the care of the older person. Med Sci (Basel). 2021;9(2):31. https:\/\/doi.org\/10.3390\/medsci9020031.","journal-title":"Med Sci (Basel)."},{"issue":"2 Pt 1","key":"1143_CR122","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.1152\/ajpendo.1991.260.2.E183","volume":"260","author":"J Born","year":"1991","unstructured":"Born J, DeKloet ER, Wenz H, Kern W, Fehm HL. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol. 1991;260(2 Pt 1):E183\u20138. https:\/\/doi.org\/10.1152\/ajpendo.1991.260.2.E183.","journal-title":"Am J Physiol"},{"issue":"4","key":"1143_CR123","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000118326","volume":"16","author":"HL Fehm","year":"1986","unstructured":"Fehm HL, Benkowitsch R, Kern W, Fehm-Wolfsdorf G, Pauschinger P, Born J. Influences of corticosteroids, dexamethasone and hydrocortisone on sleep in humans. Neuropsychobiology. 1986;16(4):198\u2013204. https:\/\/doi.org\/10.1159\/000118326.","journal-title":"Neuropsychobiology"},{"issue":"3","key":"1143_CR124","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jsmc.2018.04.012","volume":"13","author":"KL Stone","year":"2018","unstructured":"Stone KL, Xiao Q. Impact of poor sleep on physical and mental health in older women. Sleep Med Clin. 2018;13(3):457\u201365. https:\/\/doi.org\/10.1016\/j.jsmc.2018.04.012.","journal-title":"Sleep Med Clin"},{"issue":"12","key":"1143_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296028","volume":"18","author":"T Kato","year":"2023","unstructured":"Kato T, Okawa G, Tanaka KF, Mitsukura Y. Dexamethasone induces sleep disturbance in a dose-dependent manner in mice. PLoS\u00a0One. 2023;18(12): e0296028. https:\/\/doi.org\/10.1371\/journal.pone.0296028.","journal-title":"PLoS\u00a0One"},{"issue":"4","key":"1143_CR126","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJM199201233260403","volume":"326","author":"R Schlaghecke","year":"1992","unstructured":"Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992;326(4):226\u201330. https:\/\/doi.org\/10.1056\/NEJM199201233260403.","journal-title":"N Engl J Med"},{"issue":"6","key":"1143_CR127","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/jc.2015-1218","volume":"100","author":"LH Broersen","year":"2015","unstructured":"Broersen LH, Pereira AM, J\u00f8rgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171\u201380. https:\/\/doi.org\/10.1210\/jc.2015-1218.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1143_CR128","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321\u20137. https:\/\/doi.org\/10.1056\/NEJMoa011592.","journal-title":"N Engl J Med"},{"issue":"1","key":"1143_CR129","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/biomedicines11010175","volume":"11","author":"RI Arcana","year":"2023","unstructured":"Arcana RI, Cri\u0219an-Dabija R, Cernomaz AT, et al. The risk of sarcoidosis misdiagnosis and the harmful effect of corticosteroids when the disease picture is incomplete. Biomedicines. 2023;11(1):175. https:\/\/doi.org\/10.3390\/biomedicines11010175.","journal-title":"Biomedicines."},{"key":"1143_CR130","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdcr.2021.05.023","volume":"13","author":"AM Erlendsson","year":"2021","unstructured":"Erlendsson AM, L\u00f6nndahl L, Killasli H. Intermittent low-dose corticosteroid therapy for hidradenitis suppurativa: a case series. JAAD Case Rep. 2021;13:105\u20138. https:\/\/doi.org\/10.1016\/j.jdcr.2021.05.023.","journal-title":"JAAD Case Rep."},{"issue":"12","key":"1143_CR131","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.NPR.0000798224.30305.d1","volume":"46","author":"MJ Cadet","year":"2021","unstructured":"Cadet MJ. Antiretroviral therapies and corticosteroids: drug\u2013drug interactions. Nurse Pract. 2021;46(12):40\u20137. https:\/\/doi.org\/10.1097\/01.NPR.0000798224.30305.d1.","journal-title":"Nurse Pract"},{"issue":"12","key":"1143_CR132","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1345\/aph.1H418","volume":"40","author":"KA Hazlewood","year":"2006","unstructured":"Hazlewood KA, Fugate SE, Harrison DL. Effect of oral corticosteroids on chronic warfarin therapy. Ann Pharmacother. 2006;40(12):2101\u20136. https:\/\/doi.org\/10.1345\/aph.1H418.","journal-title":"Ann Pharmacother"},{"key":"1143_CR133","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2147\/TCRM.S79135","volume":"11","author":"N Moore","year":"2015","unstructured":"Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061\u201375. https:\/\/doi.org\/10.2147\/TCRM.S79135.","journal-title":"Ther Clin Risk Manag"},{"issue":"1\u20132","key":"1143_CR134","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00192355","volume":"49","author":"P Widmer","year":"1995","unstructured":"Widmer P, Maibach R, K\u00fcnzi UP, et al. Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, berne (CHDM). Eur J Clin Pharmacol. 1995;49(1\u20132):31\u20136. https:\/\/doi.org\/10.1007\/BF00192355.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1143_CR135","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1517\/17425250902967648","volume":"5","author":"YY Zhang","year":"2009","unstructured":"Zhang YY, Yang L. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications. Expert Opin Drug Metab Toxicol. 2009;5(6):621\u20139. https:\/\/doi.org\/10.1517\/17425250902967648.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1143_CR136","unstructured":"Wellbutrin (bupropion hydrochloride) US prescribing information. GlaxoSmithKline November, 2019.2.Zyban (bupropion hydrochloride) US prescribing information. GlaxoSmithKline; 2019."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01143-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:25:27Z","timestamp":1729005927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01143-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":136,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01143-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"12 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Daniel C. Butler is a consultant for Galderma and Sanofi. Kennedy Sparling has no conflicts of interest to declare that may be relevant to the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent to Participate\/Publish"}},{"value":"No sources of funding were received to assist in the preparation of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and Code Availability"}},{"value":"KS: writing\u2014original draft preparation, writing\u2014review and editing. DCB: conceptualization, validation, review and editing. Both authors read and approved the final version of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}